- Home
- ATHA vs EDTK Comparison
ATHA vs EDTK Comparison
Compare ATHA & EDTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- EDTK
- Stock Information
- Founded
- ATHA 2011
- EDTK 2013
- Country
- ATHA United States
- EDTK China
- Employees
- ATHA N/A
- EDTK N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- EDTK Other Consumer Services
- Sector
- ATHA Health Care
- EDTK Real Estate
- Exchange
- ATHA Nasdaq
- EDTK Nasdaq
- Market Cap
- ATHA 14.8M
- EDTK 15.9M
- IPO Year
- ATHA 2020
- EDTK 2020
- Fundamental
- Price
- ATHA $0.40
- EDTK $1.06
- Analyst Decision
- ATHA Hold
- EDTK
- Analyst Count
- ATHA 3
- EDTK 0
- Target Price
- ATHA $0.50
- EDTK N/A
- AVG Volume (30 Days)
- ATHA 133.3K
- EDTK 7.7K
- Earning Date
- ATHA 08-07-2025
- EDTK 08-08-2025
- Dividend Yield
- ATHA N/A
- EDTK N/A
- EPS Growth
- ATHA N/A
- EDTK N/A
- EPS
- ATHA N/A
- EDTK N/A
- Revenue
- ATHA N/A
- EDTK $893,690.00
- Revenue This Year
- ATHA N/A
- EDTK N/A
- Revenue Next Year
- ATHA N/A
- EDTK N/A
- P/E Ratio
- ATHA N/A
- EDTK N/A
- Revenue Growth
- ATHA N/A
- EDTK N/A
- 52 Week Low
- ATHA $0.22
- EDTK $0.80
- 52 Week High
- ATHA $3.51
- EDTK $1.20
- Technical
- Relative Strength Index (RSI)
- ATHA 53.29
- EDTK 57.58
- Support Level
- ATHA $0.38
- EDTK $1.00
- Resistance Level
- ATHA $0.41
- EDTK $1.17
- Average True Range (ATR)
- ATHA 0.02
- EDTK 0.06
- MACD
- ATHA -0.00
- EDTK 0.01
- Stochastic Oscillator
- ATHA 71.70
- EDTK 62.17
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About EDTK Skillful Craftsman Education Technology Limited
Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.